Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 11, 2022

Emcure Pharms Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for EMCURE PHARMS LTD, and what generic and branded alternatives to EMCURE PHARMS LTD drugs are available?

EMCURE PHARMS LTD has thirty-one approved drugs.

There is one tentative approval on EMCURE PHARMS LTD drugs.

Summary for Emcure Pharms Ltd

US Patents:	0
Tradenames:	28
Ingredients:	28
NDAs:	31

Drugs and US Patents for Emcure Pharms Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emcure Pharms Ltd	ETOMIDATE	etomidate	INJECTABLE;INJECTION	204618-001	Aug 13, 2014	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Emcure Pharms Ltd	ZOLEDRONIC ACID	zoledronic acid	INJECTABLE;INTRAVENOUS	201801-001	Mar 29, 2013		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Emcure Pharms Ltd	METOCLOPRAMIDE	metoclopramide hydrochloride	INJECTABLE;INJECTION	204756-001	Dec 20, 2013	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Emcure Pharms Ltd	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	202063-002	Sep 11, 2012		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Emcure Pharms Ltd	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	202275-001	Oct 31, 2013		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Emcure Pharms Ltd	PROPOFOL	propofol	INJECTABLE;INJECTION	206408-001	Oct 12, 2021	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

McKinsey

Boehringer Ingelheim

McKesson

AstraZeneca

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.